Insights That
Move You Forward
Helping you make smarter decisions, avoid costly missteps, and
bring safe, effective products to market with confidence
What Happens After Clinical Trial Close-Out: Transitioning to Reimbursement
Clinical trial close-out is no longer the end of the development process. In 2026, sponsors must transition quickly from regulatory evidence generation to reimbursement and market access planning. Learn how clinical strategy, real-world evidence, payer expectations, and post-market planning now shape commercialization success for medical devices and combination products.